We investigated to what extent the CAIDE dementia risk score, smoking, and depression (history of depression, or current symptoms) as modifiable risk factors were related to clinical progression of cognitive impairment in the presence or absence of Aβ and p-tau pathology. This evidence concerns the gene MAPT and depressive symptom measurement.